About this journal

Aims and scope

Breast Cancer: Targets and Therapy is an international, peer reviewed, open access journal focusing on breast cancer, basic and translational research, clinical trials and treatment. The latter includes outcome studies that incorporate preventative and integrated treatment strategies for enhanced survival, and quality of life for cancer patients.

Breast Cancer: Targets and Therapy will no longer consider meta-analyses for publication.

Specific topics covered in the journal include:

  • Epidemiology, detection and screening
  • Cellular research and biomarkers
  • Cancer stem cells
  • Cancer dormancy and metastasis
  • Novel biotargets and other agents such as small non-coding RNA
  • Drug Delivery Systems
  • Optimal clinical use of existing anti-cancer agents, including combination therapies
  • Radiation and surgery
  • Palliative care
  • Patient adherence, quality of life, satisfaction
  • Health economic evaluations

The journal welcomes submitted papers covering original research articles, reviews, basic and translational research, clinical and epidemiological studies, treatment guidelines, expert opinion and commentaries.

Breast Cancer: Targets and Therapy will no longer consider case reports/series for publication.

When considering submission of a paper utilizing publicly available data (e.g. SEER/GWAS/TCGA/GEO etc.), authors should ensure that such studies add significantly to the body of knowledge about breast cancer or relevant phenotype and that they are validated using the authors’ own data through replication in an independent sample set and functional follow-up.

All papers submitted on or after 3 August 2022 must meet these requirements.

Journal metrics

Usage

  • 103K annual downloads/views

Citation metrics

  • 3.3 (2023) Impact Factor
  • Q2 Impact Factor Best Quartile
  • 4.2 (2023) 5 year IF
  • 4.1 (2023) CiteScore (Scopus)
  • 1.009 (2023) SNIP
  • 0.933 (2023) SJR

Editorial board

Editor-in-Chief

Professor Pranela Rameshwar, Medicine-Hematology/Oncology, Rutgers New Jersey Medical School, United States

Dr. Pooja Advani, Assistant Professor of Medicine, Mayo Clinic 

Associate Editors-in-Chief

Professor Robert Clarke, Cancer Systems Biology, The Hormel Institute, University of Minnesota, United States

Professor Harikrishna Nakshatri, Breast Cancer Research, Indiana University School of Medicine, United States

Editorial Board

Prof. Dr. Emmanuel Akporiaye, Chiles Research Institute, Providence Portland Cancer Center, United States

Professor Hamid Band, Center for Breast Cancer, University of Nebraska Medical Center, United States

Dr Abhijit De, Molecular Functional Imaging Laboratory, Advanced Centre of Teaching Research and Education in Cancer, Tata Memorial Centre, Mumbai, India

Dr Hesham Elghazaly, Clinical Oncology, Ain Shams University, Cairo, Egypt

Professor Ramesh Ganju, Pathology, Ohio State University, United States

Dr Pere Gascon, Laboratory of Molecular & Translational Oncology-CELLEX C, University of Barcelona, Spain

Dr Mark Greene, John Eckman Professor of Medical Sciences, Emeritus Professor of Pathology and Laboratory Medicine, Department of Pathology and Laboratory Medicine , Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

Professor Jun-Lin Guan, Cancer Biology, University of Cincinnati, United States

Professor Jennifer Hu, Public Health Sciences, University of Miller School of Medicine, United States

Professor Phillip Koeffler, Division of Hematology and Oncology, Cedars-Sinai Medical Center, University of California, Los Angeles, CA, United States

Professor Rong Li, Department of Biochemistry & Molecular Medicine, The George Washington University, United States

Professor Dan Liebermann, Medical Genetics & Molecular Biochemistry, Temple University, Philadelphia, United States

Dr James Andrew McCubrey, Microbiology & Immunology, East Carolina University, United States

Dr Kathleen McEnnis, Assistant Professor, Department of Chemical and Materials Engineering, New Jersey Institute of Technology (NJIT), USA

Dr George Nahas, University of Miami Health System, Miami, FL, United States

Dr Jimmy S. Patel,Emory Radiation Oncology PGY2, Emory Winship Cancer Institute, United States

Professor Ratna B. Ray, Pathology, Saint Louis University School of Medicine, United States

Professor Avraham Raz, Department of Pathology and Radiation Oncology, Wayne State University, Detroit, United States

Prof. Dr. Stephen Safe, Department of Veterinary Physiology and Pharmacology, Texas A&M University, United States

Professor Edward Schwartz, Albert Einstein College of Medicine, Bronx, NY, United States

Professor Lalita R. Shevde-Samant, Department of Pathology, University of Alabama at Birmingham, United States

Dr Seema Singh, Department of Pathology, University of South Alabama, Mitchell Cancer Institute, United States

Professor Guangchao Sui, College of Life Science, Northeast Forestry University, China Mainland (PRC)

Professor Jules Sumkin, Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States

Dr Debra Tonetti, Department of Biopharmaceutical Sciences, College of Pharmacy, Chicago, IL, United States

Dr Nykia Walker, University of Maryland, United States

Professor Dennis Watson, Laboratory Medicine, Medical University of South Carolina, United States

Professor Lily Yang, Department of Surgery, Emory University School of Medicine, United States

Professor Dihua Yu, Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer, United States

Professor Howard Zaren, Lewis Cancer and Research Pavilion, at St. Joseph's/Candler Hospital System in Savannah, GA, United States

Professor Jian-Ting Zhang, Department of Cancer Biology, University of Toledo College of Medicine & Life Sciences, Ohio, United States

Abstracting and indexing

Breast Cancer: Targets and Therapy is indexed/tracked/covered by the following services:

Current Contents®/Clinical MedicineBiological Abstracts

BIOSIS Previews (Clarivate Analytics)

Directory of Open Access Journals (DOAJ)

EMBASE (Elsevier)

Journal Citation Reports/Science Edition

Medline (NLM)

Pubmed (NLM)

PubMed Central Selective Deposit Medicine & Health (NLM)

Science Citation Index Expanded (Clarivate Analytics)

Scopus (Elsevier)

Open access

Breast Cancer: Targets and Therapy is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.

Use our APC finder to calculate your article publishing charge

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors